covid-19 vaccine, the European Medicines Agency on Thursday said that the jab is not directly associated with an increase in the overall risk of blood clots, but said that further analysis is required to prove whether there is an indirect link.“Close safety monitoring of reports of blood clotting disorders will continue, and further studies are being instituted to provide more laboratory data as well as real-world evidence," the EMA said in a statement on Thursday, while adding that the panel which conducted the review—Pharmacovigilance Risk Assessment Committee—will conduct similar reviews of risks for other vaccines as well.The panel, which involved experts in blood disorders in its review, worked closely with other health authorities,.